Rigel Pharma (RIGL) Tops Q3 EPS by 146c
Tweet
Share
E-mailGet Alerts RIGL Hot Sheet
Price: $48.58 +2.27%
EPS Growth %: -34.9%
Financial Fact:
Income (loss) from operations: -22.74M
Today's EPS Names:
RCBC, GASS, YSG, More
EPS Growth %: -34.9%
Financial Fact:
Income (loss) from operations: -22.74M
Today's EPS Names:
RCBC, GASS, YSG, More
Join SI Premium – FREE
Rigel Pharma (NASDAQ: RIGL) reported Q3 EPS of $1.46. Revenue for the quarter came in at $69.46 million.
For earnings history and earnings-related data on Rigel Pharma (RIGL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Barrick Is Said to Weigh Delaying North America Gold IPO to 2027 - Bloomberg
- Quanome Technologies (QNME) files $250M mixed shelf
- NYSE uses Anthropic’s Mythos to find cyber security flaws
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
